ERBB2 and breast cancer: Having disclosed the correlation between cholesterol content in the cell membrane and the surface levels of ErbB2 receptors, we next sought to investigate the influence of the cholesterol-lowering drug lovastatin on the in vitro growth of ErbB2-positive breast cancer cell lines.